News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
372,334 Results
Type
Article (24253)
Company Profile (155)
Press Release (347912)
Multimedia
Podcasts (116)
Webinars (18)
Section
Business (111699)
Career Advice (943)
Deals (19432)
Drug Delivery (113)
Drug Development (54899)
Employer Resources (86)
FDA (8289)
Job Trends (8203)
News (197726)
Policy (18498)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1000)
Academic (1)
Accelerated approval (20)
Adcomms (23)
Allergies (83)
Alliances (29704)
ALS (103)
Alzheimer's disease (844)
Antibody-drug conjugate (ADC) (210)
Approvals (8471)
Artificial intelligence (286)
Autoimmune disease (87)
Automation (21)
Bankruptcy (183)
Best Places to Work (5859)
BIOSECURE Act (14)
Biosimilars (172)
Biotechnology (70)
Bladder cancer (82)
Brain cancer (36)
Breast cancer (278)
Cancer (2527)
Cardiovascular disease (257)
Career advice (780)
Career pathing (24)
CAR-T (144)
CDC (16)
Cell therapy (439)
Cervical cancer (11)
Clinical research (47749)
Collaboration (1074)
Company closure (1)
Compensation (408)
Complete response letters (54)
COVID-19 (1217)
CRISPR (54)
C-suite (552)
Cystic fibrosis (91)
Data (3590)
Decentralized trials (2)
Denatured (28)
Depression (85)
Diabetes (285)
Diagnostics (1989)
Digital health (16)
Diversity (10)
Diversity, equity & inclusion (25)
Drug discovery (185)
Drug pricing (200)
Drug shortages (34)
Duchenne muscular dystrophy (144)
Earnings (42989)
Editorial (46)
Employer branding (11)
Employer resources (84)
Events (55254)
Executive appointments (640)
FDA (9988)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (726)
Gene editing (111)
Generative AI (33)
Gene therapy (312)
GLP-1 (833)
Government (2164)
Grass and pollen (4)
Guidances (216)
Healthcare (6672)
HIV (29)
Huntington's disease (26)
IgA nephropathy (60)
Immunology and inflammation (180)
Immuno-oncology (36)
Indications (72)
Infectious disease (1356)
Inflammatory bowel disease (124)
Inflation Reduction Act (12)
Influenza (47)
Intellectual property (149)
Interviews (127)
IPO (7810)
IRA (53)
Job creations (2541)
Job search strategy (691)
JPM (52)
Kidney cancer (11)
Labor market (63)
Layoffs (355)
Leadership (27)
Legal (4365)
Liver cancer (41)
Longevity (9)
Lung cancer (348)
Lymphoma (250)
Machine learning (21)
Management (32)
Manufacturing (560)
MASH (104)
Medical device (2296)
Medtech (2309)
Mergers & acquisitions (12186)
Metabolic disorders (924)
Multiple sclerosis (102)
NASH (20)
Neurodegenerative disease (173)
Neuropsychiatric disorders (73)
Neuroscience (1621)
Neurotech (1)
NextGen: Class of 2026 (2628)
Non-profit (1172)
Now hiring (46)
Obesity (521)
Opinion (258)
Ovarian cancer (78)
Pain (149)
Pancreatic cancer (99)
Parkinson's disease (176)
Partnered (18)
Patents (309)
Patient recruitment (256)
Peanut (19)
People (36163)
Pharmaceutical (78)
Pharmacy benefit managers (33)
Phase 1 (15371)
Phase 2 (20341)
Phase 3 (15903)
Pipeline (3078)
Policy (241)
Postmarket research (1673)
Preclinical (5636)
Press Release (30)
Prostate cancer (132)
Psychedelics (29)
Radiopharmaceuticals (184)
Rare diseases (572)
Real estate (3409)
Recruiting (34)
Regulatory (14582)
Reports (27)
Research institute (1065)
Resumes & cover letters (147)
Rett syndrome (8)
RNA editing (13)
RSV (43)
Schizophrenia (118)
Series A (128)
Series B (83)
Service/supplier (7)
Sickle cell disease (85)
Special edition (22)
Spinal muscular atrophy (122)
Sponsored (21)
Startups (2191)
State (2)
Stomach cancer (12)
Supply chain (77)
Tariffs (94)
The Weekly (86)
Vaccines (423)
Venture capital (69)
Weight loss (378)
Women's health (43)
Worklife (9)
Date
Today (6)
Last 7 days (320)
Last 30 days (1213)
Last 365 days (16421)
2026 (1565)
2025 (16656)
2024 (19041)
2023 (21217)
2022 (27736)
2021 (28561)
2020 (26543)
2019 (21529)
2018 (16823)
2017 (18358)
2016 (17294)
2015 (20260)
2014 (15950)
2013 (13750)
2012 (14742)
2011 (14968)
2010 (13763)
Location
Africa (450)
Alabama (41)
Alaska (2)
Arizona (109)
Arkansas (8)
Asia (27760)
Australia (3855)
California (5291)
Canada (1943)
China (771)
Colorado (202)
Connecticut (220)
Delaware (202)
Europe (56448)
Florida (966)
Georgia (114)
Hawaii (3)
Idaho (27)
Illinois (456)
India (53)
Indiana (301)
Iowa (5)
Japan (326)
Kansas (88)
Kentucky (30)
Louisiana (7)
Maine (5)
Maryland (631)
Massachusetts (4110)
Michigan (74)
Minnesota (260)
Mississippi (3)
Missouri (43)
Montana (15)
Nebraska (14)
Nevada (44)
New Hampshire (10)
New Jersey (1935)
New Mexico (22)
New York (1450)
North Carolina (838)
North Dakota (2)
Northern California (2482)
Ohio (141)
Oklahoma (9)
Oregon (25)
Pennsylvania (1119)
Puerto Rico (19)
Rhode Island (27)
South America (679)
South Carolina (12)
Southern California (2236)
Tennessee (65)
Texas (694)
United States (19728)
Utah (99)
Virginia (184)
Washington D.C. (61)
Washington State (516)
West Virginia (1)
Wisconsin (52)
Wyoming (1)
372,334 Results for "stem pharm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Stem Cell Specialist PrimeGen Takes SPAC Track to Nasdaq
The SPAC agreement values PrimeGen US at $1.5 billion in equity and gives it capital to advance its pre-clinical triple-activated mesenchymal stem cell pipeline into the clinic.
February 5, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
February 3, 2026
·
7 min read
Press Releases
Pharming Group reports preliminary 2025 revenues and announces Investor Day
January 8, 2026
·
5 min read
Press Releases
Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit
December 8, 2025
·
1 min read
Press Releases
Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS
February 2, 2026
·
8 min read
Press Releases
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China
December 29, 2025
·
6 min read
Press Releases
Cellares to Expand Automated Manufacturing to Gene-Edited Stem Cell Therapies
February 4, 2026
·
3 min read
Press Releases
Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London
October 30, 2025
·
1 min read
Press Releases
ElpasBio and Fosun Kairos Announce Commercialization Collaboration for AlloJoin® Stem Cell Therapy
January 14, 2026
·
5 min read
Press Releases
Michigan Integrative Health Expands Stem Cell Therapy Services to Welcome Canadian Patients
February 4, 2026
·
2 min read
1 of 37,234
Next
